Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein

Antiviral Research

Volumn 111, Issue , 2014, Pages 69-77

  Yamada, Hiroshi ^a   Nagao, Chioko ^a   Haredy, Ahmad M ^a   Mori, Yasuko ^b   Mizuguchi, Kenji ^a   Yamanishi, Koichi ^a   Okamoto, Shigefumi ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dextran sulfate; Influenza; Neuraminidase

Indexed keywords

CHIMERIC PROTEIN; DEXTRAN SULFATE; OSELTAMIVIR; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE; ANTIVIRUS AGENT; NA PROTEIN, INFLUENZA A VIRUS; SIALIDASE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIVIRAL RESISTANCE; ARTICLE; ENZYME INHIBITION; GENE MUTATION; IN VITRO STUDY; INFLUENZA A (H1N1); INFLUENZA A VIRUS (A/PUERTO RICO/8/1934(H1N1)); MDCK CELL LINE; NONHUMAN; REVERSE GENETICS; VIRUS INHIBITION; VIRUS MUTANT; VIRUS MUTATION; VIRUS RECOMBINANT; VIRUS REPLICATION; WILD TYPE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A; METABOLISM; MISSENSE MUTATION; MOLECULAR GENETICS; PHYSIOLOGY; SEQUENCE ALIGNMENT; VIROLOGY;

ORTHOMYXOVIRIDAE;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DEXTRAN SULFATE; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEURAMINIDASE; OSELTAMIVIR; SEQUENCE ALIGNMENT; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84907539048     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.09.002     Document Type: Article

References (39)

1. R.E. Amaro, D.D. Minh, L.S. Cheng, W.M. Lindstrom Jr., A.J. Olson, J.H. Lin, W.W. Li, and J.A. McCammon Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design J. Am. Chem. Soc. 129 2007 7764 7765
2. R.E. Amaro, X. Cheng, I. Ivanov, D. Xu, and J.A. McCammon Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations J. Am. Chem. Soc. 131 2009 4702 4709
3. J. An, D.C. Lee, A.H. Law, C.L. Yang, L.L. Poon, A.S. Lau, and S.J. Jones A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase J. Med. Chem. 52 2009 2667 2672
4. N. Arnberg, A.H. Kidd, K. Edlund, J. Nilsson, P. Pring-Akerblom, and G. Wadell Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction Virology 302 2002 33 43
5. M. Baba, R. Snoeck, R. Pauwels, and E. de Clercq Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus Antimicrob. Agents Chemother. 32 1988 1742 1745
6. N.A. Baker, D. Sept, S. Joseph, M.J. Holst, and J.A. McCammon Electrostatics of nanosystems: application to microtubules and the ribosome Proc. Natl. Acad. Sci. U.S.A. 98 2001 10037 10041
7. S. Barman, L. Adhikary, A.K. Chakrabarti, C. Bernas, Y. Kawaoka, and D.P. Nayak Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding J. Virol. 78 2004 5258 5269
8. D.A. Boltz, J.R. Aldridge Jr., R.G. Webster, and E.A. Govorkova Drugs in development for influenza Drugs 70 2010 1349 1362
9. J. Carr, J. Ives, L. Kelly, R. Lambkin, J. Oxford, D. Mendel, L. Tai, and N. Roberts Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo Antiviral Res. 54 2002 79 88
10. L.S. Cheng, R.E. Amaro, D. Xu, W.W. Li, P.W. Arzberger, and J.A. McCammon Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase J. Med. Chem. 51 2008 3878 3894
11. P.M. Colman, P.A. Hoyne, and M.C. Lawrence Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase J. Virol. 67 1993 2972 2980
12. E. De Clercq Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS) J. Med. Chem. 29 1986 1561 1569
13. P. De Somer, E. De Clercq, A. Billiau, E. Schonne, and M. Claesen Antiviral activity of polyacrylic and polymethacrylic acids. I. Mode of action in vitro J. Virol. 2 1968 878 885
14. N. Eswar, B. Webb, M.A. Marti-Renom, M.S. Madhusudhan, D. Eramian, M.Y. Shen, U. Pieper, and A. Sali Comparative protein structure modeling using Modeller Curr. Protoc. Bioinform. 2006 Chapter 5, Unit 5 and 6
15. S.H. Hauge, S. Dudman, K. Borgen, A. Lackenby, and O. Hungnes Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08 Emerg. Infect. Dis. 15 2009 155 162
16. F.G. Hayden Prevention and treatment of influenza in immunocompromised patients Am. J. Med. 102 1997 55 60 discussion 75-6
17. A. Herrmann, T. Korte, K. Arnold, and B. Hillebrecht The influence of dextran sulfate on influenza A virus fusion with erythrocyte membranes Antiviral Res. 19 1992 295 311
18. E. Hoffmann, J. Stech, Y. Guan, R.G. Webster, and D.R. Perez Universal primer set for the full-length amplification of all influenza A viruses Arch. Virol. 146 2001 2275 2289
19. T. Horimoto, S. Murakami, Y. Muramoto, S. Yamada, K. Fujii, M. Kiso, K. Iwatsuki-Horimoto, Y. Kino, and Y. Kawaoka Enhanced growth of seed viruses for H5N1 influenza vaccines Virology 366 2007 23 27
20. M. Hosoya, J. Balzarini, S. Shigeta, and E. De Clercq Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins Antimicrob. Agents Chemother. 35 1991 2515 2520
21. A.C. Hurt, J. Ernest, Y.M. Deng, P. Iannello, T.G. Besselaar, C. Birch, P. Buchy, M. Chittaganpitch, S.C. Chiu, D. Dwyer, A. Guigon, B. Harrower, I.P. Kei, T. Kok, C. Lin, K. McPhie, A. Mohd, R. Olveda, T. Panayotou, W. Rawlinson, L. Scott, D. Smith, H. D'Souza, N. Komadina, R. Shaw, A. Kelso, and I.G. Barr Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa Antiviral Res. 83 2009 90 93
22. H.D. Klenk, and R. Rott The molecular biology of influenza virus pathogenicity Adv. Virus Res. 34 1988 247 281
23. M. Lüscher-Mattli, and R. Glück Dextran sulfate inhibits the fusion of influenza virus with model membranes, and suppresses influenza virus replication in vivo Antiviral Res. 14 1990 39 50
24. M. Lüscher-Mattli, R. Glück, C. Kempf, and M. Zanoni-Grassi A comparative study of the effect of dextran sulfate on the fusion and the in vitro replication of influenza A and B, Semliki Forest, vesicular stomatitis, rabies, Sendai, and mumps virus Arch. Virol. 130 1993 317 326
25. M.N. Matrosovich, T.Y. Matrosovich, T. Gray, N.A. Roberts, and H.D. Klenk Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium J. Virol. 78 2004 12665 12667
26. H. Mitsuya, D.J. Looney, S. Kuno, R. Ueno, F. Wong-Staal, and S. Broder Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells Science 240 1988 646 649
27. M. Moulard, H. Lortat-Jacob, I. Mondor, G. Roca, R. Wyatt, J. Sodroski, L. Zhao, W. Olson, P.D. Kwong, and Q.J. Sattentau Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120 J. Virol. 74 2000 1948 1960
28. G. Neumann, T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D.R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka Generation of influenza A viruses entirely from cloned cDNAs Proc. Natl. Acad. Sci. U.S.A. 96 1999 9345 9350
29. G. Neumann, T. Noda, and Y. Kawaoka Emergence and pandemic potential of swine-origin H1N1 influenza virus Nature 459 2009 931 939
30. E. Nistal-Villan, and A. Garcia-Sastre New prospects for the rational design of antivirals Nat. Med. 15 2009 1253 1254
31. M. Ohuchi, N. Asaoka, T. Sakai, and R. Ohuchi Roles of neuraminidase in the initial stage of influenza virus infection Microbes Infect. 8 2006 1287 1293
32. P. Palese, and R.W. Compans Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action J. Gen. Virol. 33 1976 159 163
33. P. Palese, K. Tobita, M. Ueda, and R.W. Compans Characterization of temperature sensitive influenza virus mutants defective in neuraminidase Virology 61 1974 397 410
34. J. Ramalho-Santos, and M.C. de Lima Fusion and infection of influenza and Sendai viruses as modulated by dextran sulfate: a comparative study Biosci. Rep. 21 2001 293 304
35. J. Shi, T.L. Blundell, and K. Mizuguchi FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties J. Mol. Biol. 310 2001 243 257
36. E. van der Vries, F.F. Stelma, and C.A. Boucher Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus N. Engl. J. Med. 363 2010 1381 1382
37. R.J. Whitley, and A.S. Monto Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents J. Infect. Dis. 194 Suppl. 2 2006 S133 S138
38. D.C. Wiley, and J.J. Skehel The structure and function of the hemagglutinin membrane glycoprotein of influenza virus Annu. Rev. Biochem. 56 1987 365 394
39. H. Yamada, E. Moriishi, A.M. Haredy, N. Takenaka, Y. Mori, K. Yamanishi, and S. Okamoto Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains Antiviral Res. 96 2012 344 352